Mannkind (MNKD) Net Equity Issued and Repurchased (2010 - 2019)
Mannkind (MNKD) posted quarterly Net Equity Issued and Repurchased of $192000.0 for Q3 2019, up 3.78% year-over-year from $185000.0 in Q3 2018, and down 84.88% quarter-over-quarter from $1.3 million in Q4 2018.
Mannkind (MNKD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Mannkind (MNKD) has reported Net Equity Issued and Repurchased for 6 consecutive years, with $192000.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Net Equity Issued and Repurchased rose 3.78% year-over-year to $192000.0; the TTM figure through Sep 2019 stood at $1.6 million (up 24.87% YoY), while the FY2018 annual figure was $2.1 million, up 270.39% from the prior year.
- Net Equity Issued and Repurchased declined to $192000.0 in Q3 2019 per MNKD's latest filing, from $1.3 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $13.9 million in Q4 2015 and bottomed at $185000.0 in Q3 2018.
- Historically, Net Equity Issued and Repurchased has averaged $4.1 million across 4 years, with a median of $634000.0 in 2018.
- Annual changes were most pronounced in 2018 — Net Equity Issued and Repurchased jumped 154.0% — and 2019, when it increased 3.78%.
- Mannkind's Net Equity Issued and Repurchased stood at $13.9 million in 2015, then tumbled by 96.39% to $500000.0 in 2017, then surged by 154.0% to $1.3 million in 2018, then plunged by 84.88% to $192000.0 in 2019.
- Business Quant data shows MNKD's Net Equity Issued and Repurchased at $192000.0 in Q3 2019, $1.3 million in Q4 2018, and $185000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 192,000.00 |
| Sep 30, 2019 | 192,000.00 |
| Dec 31, 2018 | 1.27 Mn |
| Dec 31, 2018 | 1.27 Mn |
| Sep 30, 2018 | 185,000.00 |
| Sep 30, 2018 | 185,000.00 |
| Mar 31, 2018 | 634,000.00 |
| Mar 31, 2018 | 634,000.00 |
| Dec 31, 2017 | 500,000.00 |
| Dec 31, 2017 | 500,000.00 |
| Dec 31, 2015 | 13.86 Mn |
| Dec 31, 2015 | 13.86 Mn |
| Sep 30, 2015 | 12.20 Mn |
| Sep 30, 2015 | 12.20 Mn |
| Mar 31, 2011 | 9.70 Mn |
| Mar 31, 2011 | 9.70 Mn |
| Dec 31, 2010 | 14.10 Mn |
| Dec 31, 2010 | 14.10 Mn |